MedTrace Logo

EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer

NCT02783222 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2018-01-10

No results posted yet for this study

Summary

This is a randomized study evaluating the efficacy and impact on function of two different doses of nab-Paclitaxel in elderly patients with advanced breast cancer.

Conditions

Interventions

DRUG

Nab-paclitaxel

comparison of different dosages of drug

Sponsors & Collaborators

  • Fondazione Sandro Pitigliani

    lead OTHER

Principal Investigators

  • Laura Biganzoli, MD · Azienda USL Toscana Centro - Prato

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-30
Primary Completion
2017-09-22
Completion
2017-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02783222 on ClinicalTrials.gov